Simplicity Wealth LLC Buys New Shares in The Clorox Company (NYSE:CLX)

Simplicity Wealth LLC bought a new position in The Clorox Company (NYSE:CLX - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 7,118 shares of the company's stock, valued at approximately $1,048,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Wealthcare Advisory Partners LLC boosted its stake in Clorox by 47.8% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 2,350 shares of the company's stock worth $346,000 after purchasing an additional 760 shares during the period. Pallas Capital Advisors LLC acquired a new stake in shares of Clorox in the first quarter worth $647,000. Farther Finance Advisors LLC grew its holdings in shares of Clorox by 25.4% during the first quarter. Farther Finance Advisors LLC now owns 5,872 shares of the company's stock valued at $869,000 after buying an additional 1,190 shares in the last quarter. Toth Financial Advisory Corp raised its position in Clorox by 23.5% during the first quarter. Toth Financial Advisory Corp now owns 18,741 shares of the company's stock valued at $2,760,000 after buying an additional 3,564 shares during the period. Finally, Courier Capital LLC lifted its stake in Clorox by 11.6% in the 1st quarter. Courier Capital LLC now owns 2,785 shares of the company's stock worth $410,000 after acquiring an additional 290 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The stock was purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the purchase, the director now directly owns 4,000 shares in the company, valued at $546,280. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Stock Performance

Clorox stock traded up $0.99 during trading hours on Thursday, reaching $127.25. 1,393,988 shares of the company were exchanged, compared to its average volume of 1,355,947. The Clorox Company has a 12 month low of $125.77 and a 12 month high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a 50-day moving average of $135.41 and a 200 day moving average of $149.05. The firm has a market cap of $15.68 billion, a price-to-earnings ratio of 34.77, a PEG ratio of 2.62 and a beta of 0.54.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business's revenue was down 8.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.71 EPS. As a group, research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on CLX shares. JPMorgan Chase & Co. lowered their target price on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. Morgan Stanley dropped their price objective on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Barclays decreased their target price on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research note on Wednesday, May 7th. Evercore ISI set a $140.00 price target on shares of Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. Finally, UBS Group cut their price target on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research note on Thursday, April 17th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $151.23.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.